WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a clinical-stage biotechnology company focused on developing advanced kinase inhibitor treatments targeting the tumor cell and the tumor microenvironment, today announced that Michael D. Taylor, Ph.D., Deciphera’s President and Chief Executive Officer, will present a corporate update at the JMP Securities Life Sciences Private Company Conference Series on Friday, March 27, 2015 at 11:30 a.m. ET in New York.
Help employers find you! Check out all the jobs and post your resume.
